Overview
Axon Neurosciences develops tau-targeting immunotherapy treatments for Alzheimer's disease and other tauopathies using its proprietary AADvac platform.
More in Neuropharmaceuticals
Latest industry news
China Launches World's First Full-Stack MRI-Based BCI Solution, Promising Measurable Neural Plasticity
2026-08-24 · Research
Brain Implant Uses Infrared Light to Bypass Electrode Limitations in Neural Signaling
2026-08-23 · Research
BlueWind Medical's Revi Extend Wins FDA Clearance, Extending Implant Life to 15 Years
2026-08-06 · Product
Neurofeedback Systems Market Eyes $2.95 Billion Valuation by 2035 as Clinical and Consumer Demand Converge
2026-08-05 · Industry
Company details
Category
💊 Neuropharmaceuticals
Location
Bratislava, Slovakia
Website
www.axon-neuroscience.euListed
2026-08-24
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →